WVU Headache Center
More than 36 million Americans suffer from migraine headaches. They can be debilitating, costing about $20 billion a year in medical expenses and lost productivity. In this WVU Medicine Health Report, Dr. John Phillips explains why Botox is becoming a more common treatment for chronic migraine.
A popular cosmetic treatment is proving very useful in controlling debilitating migraine headaches. Here, WVU neurologist Umer Najib, MD, explains when Botox should be explored as an approach to managing this “invisible disease.”